Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

Neuro-Oncology: The Podcast - A podcast by Neuro-Oncology - Fridays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Sponsored

Dr. Maya Graham interviews Dr. Nancy Ann Oberheim Bush about her and her team's paper entitled " Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas" published online in Neuro-Oncology in April 2021

Visit the podcast's native language site